Experience in treating psoriasis patients with the preparation Ditrastic

Mashkilleĭson, A.L.; Golousenko, I.I.

Vestnik Dermatologii i Venerologii 12: 51-52

1989


ISSN/ISBN: 0042-4609
PMID: 2633555
Document Number: 346433
The results of clinical trials of ditrastic, an agent manufactured by Orion, Finland, are analyzed. The drug contains 1.5 or 3% of ditranol. Of the 59 patients treated with this drug complete resolution of clinical eruptions was achieved in 43, the condition of 10 patients considerably improved, a partial effect was observed in 4, and no effect in 2 patients. Therefore ditrastic has proved to be a highly effective agent for the treatment of psoriasis, convenient for outpatient therapy.

Document emailed within 1 workday
Secure & encrypted payments